WaveMan
WaveMan · Company
ESQ · Esquire Financial Holdings, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

ESQ Esquire Financial (ESQ) Insider Trading, Ownership & Congress Trades

Banks · Commercial banks, nec · CIK 0001531031
Quote by TradingView
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
3
Codes C/M, not in net · $410.2K priced

What the filings say about ESQ

Insiders, 180 days
-$1.6M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$127.3K
1 notice

Esquire Financial insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Esquire Financial Holdings, Inc. insiders sold a net $1.6M of stock across 222 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Sagliocca Andrew C
Vice Chairman, President & CEO
SELL
2026-09-21 SECtraded 2026-09-18
10,000
$1.2M
+2.3%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 3.5% of the 288,798 shares held after it.
  • No other insider sold within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Vice Chairman, President & CEO Sagliocca Andrew C sold about $1.2M of ESQ on Sep 18, 2026, the largest insider sale at the company since 2025.
Mitzman Robert
Director
SELL
2026-08-03 SECtraded 2026-07-30
3,000
$388.8K
-4.8%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 2.1% of the 139,679 shares held after it.
  • No other insider sold within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Mitzman Robert sold about $388.8K of ESQ on Jul 30, 2026.
Powers Richard T
Director
SELL
2026-03-20 SECtraded 2026-03-19
2,308
$241.9K
+15.2%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Feb 6, 2025.
  • The trade is 4.0% of the 58,233 shares held after it.
  • 1 other insider sold within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Powers Richard T sold about $241.9K of ESQ on Mar 19, 2026; 1 other insider sold within 30 days.
ZISES SELIG
Director
SELL
2026-03-20 SECtraded 2026-03-19
2,000
$210.5K
+15.2%
Context
  • 195 earlier Form 4 trades (code P or S) here by this insider (195 sales), the last on Mar 18, 2026.
  • The trade is 30.8% of the 6,501 shares held after it.
  • 1 other insider sold within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ZISES SELIG sold about $210.5K of ESQ on Mar 19, 2026; 1 other insider sold within 30 days.
ZISES SELIG
Director
SELL
2026-03-20 SECtraded 2026-03-19
3,000
$315.0K
+15.2%
Context
  • 195 earlier Form 4 trades (code P or S) here by this insider (195 sales), the last on Mar 18, 2026.
  • The trade is 4.7% of the 63,533 shares held after it.
  • 1 other insider sold within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ZISES SELIG sold about $315.0K of ESQ on Mar 19, 2026; 1 other insider sold within 30 days.
222 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 217 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$1.6M over 180 days
-$1.6M over 90 days
below 78% of Banks
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
12.4% of the float short (float per yahoo 2026-10-27) · 10.4 days to cover · settled 2026-10-15
more than 98% of Banks
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch ESQ

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+21.7%12M
-9%+4%+17%+30%2025-102025-122026-022026-042026-062026-082026-10 2026-09-18 · Sagliocca Andrew C sold $1.2M2026-03-18 · ZISES SELIG sold $909.5K2026-07-30 · Mitzman Robert sold $388.8K2026-03-18 · ZISES SELIG sold $321.8K2026-03-19 · ZISES SELIG sold $315.0K2026-03-19 · Powers Richard T sold $241.9K2026-03-18 · ZISES SELIG sold $214.3K2026-03-18 · ZISES SELIG sold $212.1K2026-03-18 · ZISES SELIG sold $211.1K2026-03-19 · ZISES SELIG sold $210.5K2026-03-18 · ZISES SELIG sold $210.3K2026-03-18 · ZISES SELIG sold $160.5K2026-03-18 · ZISES SELIG sold $159.1K2026-03-18 · ZISES SELIG sold $157.7K2026-03-18 · ZISES SELIG sold $107.3K2026-09-18 · Sagliocca Andrew C filed to sell $127.3K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns ESQ: institutional holders (13F)

13F holdings, latest reported quarter
Bahl & Gaynor LLC
8,600 sh
$1.0M

Congress trades in ESQ

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

ESQ planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Sagliocca Andrew C
Filed 2026-09-18
$127.3K
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.8M
$7.0M
$1.7M
+432%
+68%
2024
$1.8M
$6.2M
$1.3M
+314%
+30%
2023
$3.1M
$4.1M
$1.9M
+160%
-2%
2022
$2.5M
$4.2M
$1.5M
+125%
+3%
2021
$2.2M
$3.6M
$1.3M
+64%
+35%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.6M sold by insiders over 180 days, $127.3K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UMBFBWFGPBPEBOFMBMGABCNEWTDCOMPCBISBAWSBFJMSB

ESQ financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
$66.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
+18.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+2.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
20.44x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
n/a
no debt line filed
FCF yield
+4.4%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
1.70x
P/E over trailing EPS growth of 12%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Net income$50.8M$43.7M$41.0M$28.5M
EPS (diluted)5.875.144.913.47
Operating cash flow$59.8M$42.2M$42.4M$38.8M
Cash$235.9M$126.3M$165.2M$164.1M
Buybacksn/an/a$286.0Kn/a
Dividends paid$5.9M$4.8M$3.7M$2.1M
SEC XBRL, fiscal years, as known on 2026-10-28

ESQ Stock Sonar score 3/7 axes

Find similar shapesCompare

ESQ ranks highest on profitability (97th percentile) and insider conviction (10th), and lowest on risk and compliance (2nd), among Banks peers.

Profitability
97
Inputs
  • Return on equity+18.3% · 97 pct, sector of 327
  • Return on assets+2.3% · 98 pct, sector of 334
  • Return on invested capitalfewer than four consecutive quarters of operating income
  • Return on capital employedfewer than four consecutive quarters of operating income
Insider conviction
10
Inputs
  • Net Form 4 buying (codes P and S), 180d-$1.6M · 21 pct, sector of 273
  • Insider buyers, 180d0 · 0 pct, sector of 273
Risk and compliance
2
Inputs
  • Short interest, % of float+12.4% · 2 pct, sector of 374
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Financial health, Growth, Institutional and government, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

ESQ filings, in plain words

Are Esquire Financial insiders buying or selling ESQ?

In the 180 days to 2026-10-28, Esquire Financial insiders were net sellers, a net $1.6M across purchases and sales reported on Form 4, by 2 sellers.

Are there planned insider sales of ESQ?

Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $127.3K of stock; the latest, by Sagliocca Andrew C, was filed 2026-09-18.

Read the full summary

In the 180 days to 2026-10-28, Esquire Financial insiders were net sellers of ESQ, a net $1.6M across purchases and sales reported on Form 4 by 2 sellers. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $127.3K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies